Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Teresa, Arcidiacono"'
Autor:
Teresa Arcidiacono, Nadia E. Foligno, Elena Brioni, Arianna Bologna, Giovanna Weber, Stefano Mora, Marco Pitea, Corrado Vitale, Giuseppe Vezzoli
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 8, p 2906 (2023)
Burosumab is a monoclonal anti-FGF23 antibody used to treat patients with X-linked hypophosphatemic rickets (XLH). Its effect on serum phosphate and physical performance was compared in patients during a 6-month treatment with burosumab. Eight adult
Externí odkaz:
https://doaj.org/article/4a18e86c31e54e70af0af18676673014
Publikováno v:
Giornale di Clinica Nefrologia e Dialisi, Vol 32, Iss 1 (2020)
Citrate is an organic compound involved in tricarboxylic acid cycle, regulation of acid-base balance, lipid metabolism and bone formation. The 90% of body citrate is deposited in bone tissue and is released with calcium ions during bone resorption; t
Externí odkaz:
https://doaj.org/article/8a4f471bbef841ca8841fae7c12a7315
Publikováno v:
Giornale di Clinica Nefrologia e Dialisi, Vol 30, Iss 3-4 (2018)
Abstract non disponibile
Externí odkaz:
https://doaj.org/article/8918bcdb051349b09011d15baf01ec00
Publikováno v:
Giornale di Clinica Nefrologia e Dialisi, Vol 26, Iss 3 (2018)
Abstract non disponibile
Externí odkaz:
https://doaj.org/article/a427d475692a413ab7469e215fe866cd
Autor:
Teresa Del Mastro, Teresa Arcidiacono, Arianna Bologna, Nadia Edvige Foligno, Monica Avino, Giuseppe Vezzoli
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Irisin is a circulating myokine released by skeletal muscle after exercise. Its production decreases in chronic kidney disease (CKD) as a potential consequence of sarcopenia and physical inactivity. Irisin produces beneficial effe
Autor:
Arianna Bologna, Nadia Edvige Foligno, Monica Avino, Teresa Del Mastro, Ferruccio Conte, Nicola Palmieri, Sergio Bisegna, Giorgio Slaviero, Teresa Arcidiacono, Giuseppe Vezzoli
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Indoxyl sulphate (IS) and Cresyl sulphate (CS) are uremic toxins generated by the intestinal amino acid catabolism. Blood levels of these toxins increase in patients with CKD and are linked to cardiovascular events. Therefore, we
Autor:
Nadia Edvige Foligno, Teresa Arcidiacono, Arianna Bologna, Elena Brioni, Teresa Del Mastro, Monica Avino, Giuseppe Vezzoli
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS X-linked hypophosphoremic rickets (XLH) is a rare disease caused by mutations in the PHEX gene leading to an increase in the serum levels of FGF23, which inhibits the tubular reabsorption of phosphates and the production of 1,25(O
Publikováno v:
Giornale di Clinica Nefrologia e Dialisi, Vol 32, Iss 1 (2020)
Citrate is an organic compound involved in tricarboxylic acid cycle, regulation of acid-base balance, lipid metabolism and bone formation. The 90% of body citrate is deposited in bone tissue and is released with calcium ions during bone resorption; t
Autor:
Teresa Arcidiacono, Lorenza Macrina, Simone Premaschi, Arianna Bologna, Giulia Magni, Nadia Foligno, Monica Avino, Cristina Belloni, Nicola Palmieri, Ferruccio Conte, Sergio Bisegna, Marco Simonini, Giorgio Slaviero, Massimo Locatelli, Giuseppe Vezzoli
Publikováno v:
Journal of nephrology. 35(5)
Indoxyl sulfate (IS) and p-cresyl sulfate (PCS) are uremic toxins associated with cardiovascular outcome in CKD patients. The present work is an analysis of the association of serum free, total IS and PCS with cardiovascular events and calcium-phosph